Industry / South Africa
Clinical Trial Controversy Focuses On Regulatory Approvals Process
October 2007 | Company News AlertThe controversy that surrounded early-stage clinical trials of experimental HIV/AIDS treatment Virodene P058 (dimethylformamide) is threatening to resurface in South Africa. HIV/AIDS lobby group the Treatment Action Campaign is leading calls for a judicial investigation into the approval and blaming the President's Office for pushing it through without the green-light from the Medicines' Control Council
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
